141P Soft tissue sarcoma: A real-world analysis in a tertiary care centre from Northeast India
Soft tissue sarcomas (STSs), accounting for ∼1% of all cancers, encompass a heterogeneous group of histopathological subtypes. Outcomes are notably improved following complete surgical resection, with perioperative radiotherapy and/or chemotherapy enhancing disease-free survival (DFS) and overall survival (OS). Despite these advancements, the 5-year survival probability remains around 50%. Advanced STSs demonstrate poor chemotherapy response, with short progression-free survival and OS typically <2 years.
Authors
- Partha Roy (ORCID: https://orcid.org/0000-0002-4946-8531)
- Apurba Kumar Kalita (ORCID: https://orcid.org/0000-0002-7945-7411)
- G. P. Das (ORCID: https://orcid.org/0000-0002-0867-7732)
- A. K. Bhattacharyya (ORCID: https://orcid.org/0000-0002-4098-3318)
- Lopa Mudra Kakoti (ORCID: https://orcid.org/0000-0003-2458-914X)
Institutions
- Bhubaneswar Borooah Cancer Institute (IN)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104454
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00